Chargement en cours...
Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...
Enregistré dans:
| Publié dans: | Front Med (Lausanne) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5712546/ https://ncbi.nlm.nih.gov/pubmed/29238707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00211 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|